A blood test, combined with an ultrathin material derived from graphite, could significantly advance efforts to detect Alzheimer’s disease at its very earliest stage, even before symptoms appear.
By Vittoria D’Alessio
Alzheimer’s disease is the most common form of dementia. For millions of Europeans – and the health services that care for them – it is a ticking time bomb, with still no cure. But EU-funded researchers are developing a
